Published in Eur Urol on June 02, 2012
The role of focal therapy in the management of localised prostate cancer: a systematic review. Eur Urol (2013) 1.84
Preventing perioperative complications of robotic-assisted radical prostatectomy. Urology (2013) 1.48
Comparison of Robot-Assisted Radical Prostatectomy and Open Radical Prostatectomy Outcomes: A Systematic Review and Meta-Analysis. Yonsei Med J (2016) 1.42
Robotic-assisted colorectal surgery in the United States: a nationwide analysis of trends and outcomes. World J Surg (2013) 1.15
Diffusion of robotics into clinical practice in the United States: process, patient safety, learning curves, and the public health. World J Urol (2012) 0.95
Use of biological mesh in trans-anal treatment for recurrent recto-urethral fistula. Int Urol Nephrol (2017) 0.91
Robotic-assisted radical prostatectomy after the first decade: surgical evolution or new paradigm. ISRN Urol (2013) 0.82
Circulating Long Noncoding RNA as a Potential Target for Prostate Cancer. Int J Mol Sci (2015) 0.81
Comparison of Acute Kidney Injury After Robot-Assisted Laparoscopic Radical Prostatectomy Versus Retropubic Radical Prostatectomy: A Propensity Score Matching Analysis. Medicine (Baltimore) (2016) 0.80
Robotic-laparoscopic rectal cancer excision versus traditional laparoscopy. JSLS (2014) 0.80
Robotic general surgery: current practice, evidence, and perspective. Langenbecks Arch Surg (2015) 0.80
Perioperative Blood Transfusion as a Significant Predictor of Biochemical Recurrence and Survival after Radical Prostatectomy in Patients with Prostate Cancer. PLoS One (2016) 0.78
Efficacy of robotic-assisted prostatectomy in localized prostate cancer: a systematic review of clinical trials. Adv Urol (2013) 0.78
Robot-Assisted Radical Prostatectomy After Previous Prostate Surgery. JSLS (2015) 0.78
[The Clavien-Dindo classification of complications used for radical prostatectomy]. Wien Med Wochenschr (2014) 0.78
Predictive factors for lymph node positivity in patients undergoing extended pelvic lymphadenectomy during robot assisted radical prostatectomy. Indian J Urol (2015) 0.77
Robot-assisted versus other types of radical prostatectomy: population-based safety and cost comparison in Japan, 2012-2013. Cancer Sci (2014) 0.77
The science of vacuum erectile device in penile rehabilitation after radical prostatectomy. Transl Androl Urol (2013) 0.76
Erectile dysfunction in robotic radical prostatectomy: Outcomes and management. Indian J Urol (2014) 0.75
4-Ports endoscopic extraperitoneal radical prostatectomy: preliminary and learning curve results. Int Braz J Urol (2016) 0.75
Robotic radical prostatectomy in high-risk prostate cancer: current perspectives. Asian J Androl (2015) 0.75
Robot-assisted laparoscopic total extraperitoneal hernia repair during prostatectomy: technique and initial experience. Cent European J Urol (2015) 0.75
Avoiding and managing vascular injury during robotic-assisted radical prostatectomy. Ther Adv Urol (2015) 0.75
Dynamic Arterial Elastance in Predicting Arterial Pressure Increase After Fluid Challenge During Robot-Assisted Laparoscopic Prostatectomy: A Prospective Observational Study. Medicine (Baltimore) (2015) 0.75
Prostate cancer: epidemiologic studies and changing clinical practice. Nat Rev Urol (2012) 0.75
Obesity is associated with decreased lung compliance and hypercapnia during robotic assisted surgery. J Clin Monit Comput (2016) 0.75
Human and robot: an amity not a discord. Transl Androl Urol (2017) 0.75
Comparison of perioperative, functional, and oncologic outcomes between standard laparoscopic and robotic-assisted radical prostatectomy: a systemic review and meta-analysis. Surg Endosc (2016) 0.75
Surgical method influences specimen margins and biochemical recurrence during radical prostatectomy for high-risk prostate cancer: a systematic review and meta-analysis. World J Urol (2017) 0.75
Intraoperative workload in robotic surgery assessed by wearable motion tracking sensors and questionnaires. Surg Endosc (2016) 0.75
The surgical approach can be determined from the pathological specimen obtained after open or robot-assisted laparoscopic radical prostatectomy. World J Urol (2013) 0.75
Extraperitoneal vs. transperitoneal robot-assisted radical prostatectomy in patients with a history of prior inguinal hernia repair with mesh. J Robot Surg (2017) 0.75
Integrative genomic profiling of human prostate cancer. Cancer Cell (2010) 23.61
Abiraterone in metastatic prostate cancer without previous chemotherapy. N Engl J Med (2012) 15.69
Effect of dutasteride on the risk of prostate cancer. N Engl J Med (2010) 12.78
Denosumab and bone-metastasis-free survival in men with castration-resistant prostate cancer: results of a phase 3, randomised, placebo-controlled trial. Lancet (2011) 8.81
Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study. Eur Urol (2006) 7.13
Effects of Testosterone Treatment in Older Men. N Engl J Med (2016) 6.66
EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2013. Eur Urol (2013) 6.54
Women's groups practising participatory learning and action to improve maternal and newborn health in low-resource settings: a systematic review and meta-analysis. Lancet (2013) 6.15
The surgical learning curve for prostate cancer control after radical prostatectomy. J Natl Cancer Inst (2007) 6.12
NCCN clinical practice guidelines in oncology: prostate cancer. J Natl Compr Canc Netw (2010) 5.98
Effect of a participatory intervention with women's groups on birth outcomes and maternal depression in Jharkhand and Orissa, India: a cluster-randomised controlled trial. Lancet (2010) 5.17
Postoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy. J Clin Oncol (2005) 4.89
Radical prostatectomy: long-term cancer control and recovery of sexual and urinary function ("trifecta"). Urology (2005) 4.71
Retropubic, laparoscopic, and robot-assisted radical prostatectomy: a systematic review and cumulative analysis of comparative studies. Eur Urol (2009) 4.58
Community participation: lessons for maternal, newborn, and child health. Lancet (2008) 4.55
A nomogram predicting 10-year life expectancy in candidates for radical prostatectomy or radiotherapy for prostate cancer. J Clin Oncol (2007) 4.37
Effect of scaling up women's groups on birth outcomes in three rural districts in Bangladesh: a cluster-randomised controlled trial. Lancet (2010) 4.19
Effect of testosterone replacement on response to sildenafil citrate in men with erectile dysfunction: a parallel, randomized trial. Ann Intern Med (2012) 4.18
Preoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy. J Natl Cancer Inst (2006) 4.14
Salvage radiotherapy for recurrent prostate cancer after radical prostatectomy. JAMA (2004) 4.10
Defining biochemical recurrence of prostate cancer after radical prostatectomy: a proposal for a standardized definition. J Clin Oncol (2006) 4.05
EAU guidelines on prostate cancer. Part II: Treatment of advanced, relapsing, and castration-resistant prostate cancer. Eur Urol (2011) 4.01
Effects of pathologic stage on the learning curve for radical prostatectomy: evidence that recurrence in organ-confined cancer is largely related to inadequate surgical technique. Eur Urol (2008) 3.93
Pelvic lymph node dissection in prostate cancer. Eur Urol (2009) 3.93
Metastasis after radical prostatectomy or external beam radiotherapy for patients with clinically localized prostate cancer: a comparison of clinical cohorts adjusted for case mix. J Clin Oncol (2010) 3.76
Prostate cancer-specific mortality after radical prostatectomy for patients treated in the prostate-specific antigen era. J Clin Oncol (2009) 3.74
Long-term outcomes of patients with lymph node metastasis treated with radical prostatectomy without adjuvant androgen-deprivation therapy. Eur Urol (2013) 3.65
Guidelines on male sexual dysfunction: erectile dysfunction and premature ejaculation. Eur Urol (2010) 3.55
Effect of nightly versus on-demand vardenafil on recovery of erectile function in men following bilateral nerve-sparing radical prostatectomy. Eur Urol (2008) 3.50
Neonatal survival: a call for action. Lancet (2005) 3.44
Preoperative aspects and dimensions used for an anatomical (PADUA) classification of renal tumours in patients who are candidates for nephron-sparing surgery. Eur Urol (2009) 3.39
Predicting 15-year prostate cancer specific mortality after radical prostatectomy. J Urol (2011) 3.36
Impact of statin use on oncologic outcomes in patients with urothelial carcinoma of the bladder treated with radical cystectomy. J Urol (2013) 3.35
The effects of combination therapy with dutasteride and tamsulosin on clinical outcomes in men with symptomatic benign prostatic hyperplasia: 4-year results from the CombAT study. Eur Urol (2009) 3.31
Systematic review and meta-analysis of studies reporting oncologic outcome after robot-assisted radical prostatectomy. Eur Urol (2012) 3.26
Location, extent and number of positive surgical margins do not improve accuracy of predicting prostate cancer recurrence after radical prostatectomy. J Urol (2009) 3.24
Efficacy and tolerability of dapoxetine in treatment of premature ejaculation: an integrated analysis of two double-blind, randomised controlled trials. Lancet (2006) 3.23
Comparative effectiveness of prostate cancer surgical treatments: a population based analysis of postoperative outcomes. J Urol (2010) 3.18
Assessing the impact of ischaemia time during partial nephrectomy. Eur Urol (2009) 3.18
A non-cancer-related survival benefit is associated with partial nephrectomy. Eur Urol (2011) 3.18
Comparison of mortality outcomes after radical prostatectomy versus radiotherapy in patients with localized prostate cancer: a population-based analysis. Int J Urol (2012) 3.17
Prognostic value of histologic subtypes in renal cell carcinoma: a multicenter experience. J Clin Oncol (2005) 3.15
Tension-free midurethral slings in the treatment of female stress urinary incontinence: a systematic review and meta-analysis of randomized controlled trials of effectiveness. Eur Urol (2007) 3.14
Characteristics and outcomes of patients with clinical T1 grade 3 urothelial carcinoma treated with radical cystectomy: results from an international cohort. Eur Urol (2009) 3.14
Outcomes of radical nephroureterectomy: a series from the Upper Tract Urothelial Carcinoma Collaboration. Cancer (2009) 3.12
Contemporary open and robotic radical prostatectomy practice patterns among urologists in the United States. J Urol (2012) 3.12
Integrative genomic analyses reveal an androgen-driven somatic alteration landscape in early-onset prostate cancer. Cancer Cell (2013) 3.08
The rate of secondary malignancies after radical prostatectomy versus external beam radiation therapy for localized prostate cancer: a population-based study on 17,845 patients. Int J Radiat Oncol Biol Phys (2010) 3.06
Safety and efficacy of partial nephrectomy for all T1 tumors based on an international multicenter experience. J Urol (2004) 3.06
Perioperative outcomes of robot-assisted radical prostatectomy compared with open radical prostatectomy: results from the nationwide inpatient sample. Eur Urol (2011) 3.03
The effect of tumor location on prognosis in patients treated with radical nephroureterectomy at Memorial Sloan-Kettering Cancer Center. Eur Urol (2010) 3.02
Insignificant prostate cancer and active surveillance: from definition to clinical implications. Eur Urol (2009) 2.97
The effect of increased coverage of participatory women's groups on neonatal mortality in Bangladesh: A cluster randomized trial. JAMA Pediatr (2013) 2.95
European guidelines on upper tract urothelial carcinomas: 2013 update. Eur Urol (2013) 2.93
Association between erectile dysfunction and coronary artery disease. Role of coronary clinical presentation and extent of coronary vessels involvement: the COBRA trial. Eur Heart J (2006) 2.91
Prediction of significant prostate cancer diagnosed 20 to 30 years later with a single measure of prostate-specific antigen at or before age 50. Cancer (2010) 2.90
The role of SPINK1 in ETS rearrangement-negative prostate cancers. Cancer Cell (2008) 2.87
Best practices in robot-assisted radical prostatectomy: recommendations of the Pasadena Consensus Panel. Eur Urol (2012) 2.84